Stephan Windecker

Showing 1-20 of 173 articles

Coronary interventions

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI) A branch of the European Society of Cardiology

Van Belle E, Teles RC, Pyxaras S, Kalpak O, Johnson T, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio AS, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

July 7, 2020 | 10.4244/EIJ-D-18-00448

Coronary interventions

Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis

Spirito A, Gargiulo G, Siontis G, Mitsis A, Billinger M, Windecker S, Valgimigli M

July 7, 2020 | 10.4244/EIJ-D-20-00221

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

Chieffo A, Stefanini G, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan G, Gilard M, Halvorsen S, Huber K, James S, Neumann F, Möllmann H, Roffi M, Tavazzi G, Ferré J, Windecker S, Dudek D, Baumbach A

June 25, 2020 | 10.4244/EIJY20M05_01

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

Roffi M, Capodanno D, Windecker S, Baumbach A, Dudek D

June 25, 2020 | 10.4244/EIJ-D-20-00528

Left atrial appendage closure versus medical therapy for atrial fibrillation: the APPLY study

Gloekler S, Fürholz M, de Marchi S, Kleinecke C, Streit S, Buffle E, Fankhauser M, Häner J, Nietlispach F, Galea R, Windecker S, Meier B

June 23, 2020 | 10.4244/EIJ-D-20-00201

Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure

Kleinecke C, Fuerholz M, Buffle E, de Marchi S, Schnupp S, Brachmann J, Nietlispach F, Fankhauser M, Streit S, Windecker S, Meier B, Gloekler S

June 12, 2020 | 10.4244/EIJ-D-19-00442

Coronary interventions

Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five years clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrie D, Sabate M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys P

June 9, 2020 | 10.4244/EIJ-D-20-00024

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

Roffi M, Capodanno D, Windecker S, Baumbach A, Dudek D

June 3, 2020 | 10.4244/EIJ-D-20-00528

Coronary interventions

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys P, Hamm C, Steg P, Heg D, Branca M, Jüni P, Windecker S, Valgimigli M, Benit E, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Liebetrau C

June 2, 2020 | 10.4244/EIJ-D-20-00145

Interventions for valvular disease

Transcatheter treatment of multivalvular heart disease

Winkel MG, Brugger N, Hunziker L, Windecker S, Praz F

May 19, 2020 | 10.4244/EIJ-D-20-00244

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

May 14, 2020 | 10.4244/EIJY20M05_01

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabate M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg P, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

April 3, 2020 | 10.4244/EIJ-D-19-00699

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabate M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Coronary interventions

Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

February 18, 2020 | 10.4244/EIJ-D-20-00052

Interventions for valvular disease

Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

February 7, 2020 | 10.4244/EIJ-D-19-00797

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Will the Evolut Low Risk trial change my practice?

O'Sullivan C, Reardon M, Søndergaard L, Treede H, Jüni P, Windecker S

December 20, 2019 | 10.4244/EIJ-D-19-00587

Will the PARTNER 3 Low Risk Trial change my practice?

McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon M

December 20, 2019 | 10.4244/EIJ-D-19-00847

Coronary interventions

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabate M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg G, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

December 17, 2019 | 10.4244/EIJ-D-19-00699

Are all DES equal at 10-year follow-up?

Bär S, Windecker S, Räber L

December 6, 2019 | 10.4244/EIJV15I11A176

Latest news

NEW ISSUE

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

June 25, 2020

NEW

Ahead of print: EAPCI Core Curriculum for PCI (2020)

July 7, 2020

Editorial

IVUS guidance during left main PCI: not if, but when and how

Akiko Maehara

July 8, 2020

NEW

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

July 6, 2020

Editorial

Left main PCI: are we giving the kiss the attention it deserves?

July 8, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

JAA

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Stephan Windecker

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke